17-68271611-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_004694.5(SLC16A6):c.549C>T(p.Leu183Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00581 in 1,613,962 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0037 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0060 ( 36 hom. )
Consequence
SLC16A6
NM_004694.5 synonymous
NM_004694.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.168
Genes affected
SLC16A6 (HGNC:10927): (solute carrier family 16 member 6) Predicted to enable monocarboxylic acid transmembrane transporter activity. Predicted to be involved in monocarboxylic acid transport. Predicted to be located in membrane. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
ARSG (HGNC:24102): (arylsulfatase G) The protein encoded by this gene belongs to the sulfatase enzyme family. Sulfatases hydrolyze sulfate esters from sulfated steroids, carbohydrates, proteoglycans, and glycolipids. They are involved in hormone biosynthesis, modulation of cell signaling, and degradation of macromolecules. This protein displays arylsulfatase activity at acidic pH, as is typical of lysosomal sulfatases, and has been shown to localize in the lysosomes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 17-68271611-G-A is Benign according to our data. Variant chr17-68271611-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2648150.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.168 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A6 | NM_004694.5 | c.549C>T | p.Leu183Leu | synonymous_variant | Exon 5 of 6 | ENST00000580666.6 | NP_004685.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00374 AC: 569AN: 152212Hom.: 3 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
569
AN:
152212
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00418 AC: 1051AN: 251274 AF XY: 0.00409 show subpopulations
GnomAD2 exomes
AF:
AC:
1051
AN:
251274
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00603 AC: 8809AN: 1461632Hom.: 36 Cov.: 33 AF XY: 0.00580 AC XY: 4215AN XY: 727052 show subpopulations
GnomAD4 exome
AF:
AC:
8809
AN:
1461632
Hom.:
Cov.:
33
AF XY:
AC XY:
4215
AN XY:
727052
Gnomad4 AFR exome
AF:
AC:
39
AN:
33476
Gnomad4 AMR exome
AF:
AC:
68
AN:
44720
Gnomad4 ASJ exome
AF:
AC:
21
AN:
26132
Gnomad4 EAS exome
AF:
AC:
1
AN:
39696
Gnomad4 SAS exome
AF:
AC:
75
AN:
86256
Gnomad4 FIN exome
AF:
AC:
129
AN:
53416
Gnomad4 NFE exome
AF:
AC:
8103
AN:
1111774
Gnomad4 Remaining exome
AF:
AC:
361
AN:
60394
Heterozygous variant carriers
0
477
954
1430
1907
2384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00374 AC: 569AN: 152330Hom.: 3 Cov.: 32 AF XY: 0.00320 AC XY: 238AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
569
AN:
152330
Hom.:
Cov.:
32
AF XY:
AC XY:
238
AN XY:
74482
Gnomad4 AFR
AF:
AC:
0.00101025
AN:
0.00101025
Gnomad4 AMR
AF:
AC:
0.00254902
AN:
0.00254902
Gnomad4 ASJ
AF:
AC:
0.000864553
AN:
0.000864553
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000414766
AN:
0.000414766
Gnomad4 FIN
AF:
AC:
0.00216573
AN:
0.00216573
Gnomad4 NFE
AF:
AC:
0.00667353
AN:
0.00667353
Gnomad4 OTH
AF:
AC:
0.00236295
AN:
0.00236295
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
SLC16A6: BP4, BP7, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at